Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Moore

Showing results (1371-1380 of 1,421) with videos related to

Pageof 143
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2023
Food and Drug Administration Public Workshop Summary-Development Considerations of Antifungal Drugs to Address Unmet Medical NeedYuliya Yasinskaya, Shukal Bala, Ursula Waack, et al.
Annals of Internal Medicine|September 1, 1982
The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual menD P Francis, S C Hadler, S E Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2023
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian CancerRachel N Grisham, Ignace Vergote, Susana Banerjee, et al.
Science Translational Medicine|September 10, 2020
Therapeutic responses to <i>Roseomonas mucosa</i> in atopic dermatitis may involve lipid-mediated TNF-related epithelial repairIan A Myles, Carlo R Castillo, Kent D Barbian, et al.
Science Immunology|May 16, 2023
Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primatesNanda Kishore Routhu, Samuel David Stampfer, Lilin Lai, et al.
Nature Communications|April 26, 2024
Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaquesJaclyn A Kaiser, Christine E Nelson, Xueqiao Liu, et al.
The Journal of Clinical Investigation|August 27, 2021
Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infectionMichelle Meyer, Yuan Wang, Darin Edwards, et al.
Immunity|July 16, 2021
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challengeAnthony T DiPiazza, Sarah R Leist, Olubukola M Abiona, et al.
The New England Journal of Medicine|December 6, 2023
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian CancerKathleen N Moore, Antoine Angelergues, Gottfried E Konecny, et al.
The Lancet. Oncology|April 3, 2025
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trialToon Van Gorp, Kathleen N Moore, Gottfried E Konecny, et al.
Pageof 143

Showing results (1371-1380 of 1,421) with videos related to

Sort By:
Pageof 143
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2023
Food and Drug Administration Public Workshop Summary-Development Considerations of Antifungal Drugs to Address Unmet Medical NeedYuliya Yasinskaya, Shukal Bala, Ursula Waack, et al.
Annals of Internal Medicine|September 1, 1982
The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual menD P Francis, S C Hadler, S E Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2023
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian CancerRachel N Grisham, Ignace Vergote, Susana Banerjee, et al.
Science Translational Medicine|September 10, 2020
Therapeutic responses to <i>Roseomonas mucosa</i> in atopic dermatitis may involve lipid-mediated TNF-related epithelial repairIan A Myles, Carlo R Castillo, Kent D Barbian, et al.
Science Immunology|May 16, 2023
Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primatesNanda Kishore Routhu, Samuel David Stampfer, Lilin Lai, et al.
Nature Communications|April 26, 2024
Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaquesJaclyn A Kaiser, Christine E Nelson, Xueqiao Liu, et al.
The Journal of Clinical Investigation|August 27, 2021
Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infectionMichelle Meyer, Yuan Wang, Darin Edwards, et al.
Immunity|July 16, 2021
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challengeAnthony T DiPiazza, Sarah R Leist, Olubukola M Abiona, et al.
The New England Journal of Medicine|December 6, 2023
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian CancerKathleen N Moore, Antoine Angelergues, Gottfried E Konecny, et al.
The Lancet. Oncology|April 3, 2025
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trialToon Van Gorp, Kathleen N Moore, Gottfried E Konecny, et al.
Pageof 143